Melanotan II (MT-2) is a synthetic peptide analogue of alpha-melanocyte stimulating hormone (α-MSH), a naturally occurring hormone involved in the regulation of pigmentation and melanocortin receptor signalling.

The peptide was originally developed during research investigating how melanocortin peptides interact with receptors that regulate melanin production, appetite signalling, and energy balance. Because melanocortin receptors influence multiple physiological processes, synthetic analogues such as Melanotan II have become valuable tools in biochemical research.

Researchers continue to study MT-2 in laboratory environments exploring melanocortin receptor activity, pigmentation signalling pathways, and neuroendocrine regulation mechanisms.

Melanotan II: Quick Facts

Chemical Properties & Molecular Data

Melanotan II is a synthetic cyclic heptapeptide designed to replicate certain biological properties of the natural hormone α-melanocyte stimulating hormone.

The cyclic structure of MT-2 improves stability compared with linear peptide hormones. Structural modifications allow the peptide to interact with melanocortin receptors more effectively in laboratory studies.

Melanocortin receptor signalling plays an important role in multiple biological processes including pigmentation, appetite regulation, and neuroendocrine signalling, which explains why synthetic analogues of these hormones are widely studied in research environments.

Mechanism of Action

In laboratory studies, Melanotan II is primarily investigated for its interaction with melanocortin receptor signalling pathways.

Research suggests the peptide may influence:

• melanocortin receptor activation
• melanin synthesis signalling pathways
• neuroendocrine signalling processes
• appetite and metabolic signalling pathways

Activation of melanocortin receptors triggers intracellular signalling cascades that regulate pigmentation and other physiological processes.

These signalling pathways are part of the broader melanocortin hormone system, which plays a role in regulating multiple biological functions.

Areas of Scientific Research

Melanotan II has been studied in several areas of peptide and endocrine research.

Common research topics include:

• melanocortin receptor signalling
• pigmentation biology and melanin synthesis
• neuroendocrine signalling pathways
• appetite regulation mechanisms
• peptide hormone receptor interaction studies

These research areas help scientists better understand how melanocortin hormones influence cellular signalling and physiological regulation.

Reconstitution of Melanotan II

In research environments, Melanotan II is commonly supplied as a lyophilised peptide powder in order to preserve stability during storage and transport.

Before use in laboratory studies, the peptide must be reconstituted into solution using a sterile solvent suitable for research purposes. Solvents such as bacteriostatic water or sterile laboratory water are commonly used.

The solvent is typically introduced slowly along the inside wall of the vial, allowing the peptide powder to dissolve gradually. Gentle swirling may assist dissolution, while vigorous shaking is generally avoided to maintain peptide stability.

Researchers often determine the desired solution concentration before preparing peptide solutions. You can use our Peptide Calculator to estimate dilution ratios and final solution concentrations based on vial strength and solvent volume.

Storage of Melanotan II

Proper storage conditions are important for maintaining the stability and structural integrity of research peptides.

Lyophilised peptides are generally stored in cool, dry laboratory conditions, often under refrigeration or freezing temperatures to preserve long-term stability.

Protecting peptide samples from moisture, light exposure, and temperature fluctuations helps minimise degradation.

After reconstitution, peptide solutions are typically stored at lower temperatures and handled according to standard laboratory procedures to maintain stability during research studies.

References

1. Cone, R.D. (2006). Studies on melanocortin receptor biology and signalling.
   
2. Hadley, M.E., & Dorr, R.T. (2006). Melanocortin peptides and their receptors.
   
3. Hruby, V.J., et al. (1995). Design of melanocortin receptor agonists including Melanotan analogues.